BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23248183)

  • 1. MicroRNA in non-melanoma skin cancer.
    Sand M; Sand D; Altmeyer P; Bechara FG
    Cancer Biomark; 2012; 11(6):253-7. PubMed ID: 23248183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma.
    Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in malignant melanoma.
    Völler D; Ott C; Bosserhoff A
    Clin Biochem; 2013 Jul; 46(10-11):909-17. PubMed ID: 23360785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
    Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
    J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNAs in melanoma.
    Luo C; Weber CE; Osen W; Bosserhoff AK; Eichmüller SB
    Eur J Cell Biol; 2014; 93(1-2):11-22. PubMed ID: 24602414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA regulation of melanoma progression.
    Bonazzi VF; Stark MS; Hayward NK
    Melanoma Res; 2012 Apr; 22(2):101-13. PubMed ID: 22209751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA Dysregulation in Cutaneous Squamous Cell Carcinoma.
    García-Sancha N; Corchado-Cobos R; Pérez-Losada J; Cañueto J
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31052530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression levels of the microRNA processing enzymes Drosha and dicer in epithelial skin cancer.
    Sand M; Gambichler T; Skrygan M; Sand D; Scola N; Altmeyer P; Bechara FG
    Cancer Invest; 2010 Jul; 28(6):649-53. PubMed ID: 20210522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is miRNA Regulation the Key to Controlling Non-Melanoma Skin Cancer Evolution?
    Tamas T; Baciut M; Nutu A; Bran S; Armencea G; Stoia S; Manea A; Crisan L; Opris H; Onisor F; Baciut G; Crisan B; Opris D; Bumbu B; Tamas A; Dinu C
    Genes (Basel); 2021 Nov; 12(12):. PubMed ID: 34946878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Squamous cell carcinoma of the skin shows a distinct microRNA profile modulated by UV radiation.
    Dziunycz P; Iotzova-Weiss G; Eloranta JJ; Läuchli S; Hafner J; French LE; Hofbauer GF
    J Invest Dermatol; 2010 Nov; 130(11):2686-9. PubMed ID: 20574436
    [No Abstract]   [Full Text] [Related]  

  • 11. Expression levels of the microRNA maturing microprocessor complex component DGCR8 and the RNA-induced silencing complex (RISC) components argonaute-1, argonaute-2, PACT, TARBP1, and TARBP2 in epithelial skin cancer.
    Sand M; Skrygan M; Georgas D; Arenz C; Gambichler T; Sand D; Altmeyer P; Bechara FG
    Mol Carcinog; 2012 Nov; 51(11):916-22. PubMed ID: 22025453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma.
    Xu X; Chen Z; Zhao X; Wang J; Ding D; Wang Z; Tan F; Tan X; Zhou F; Sun J; Sun N; Gao Y; Shao K; Li N; Qiu B; He J
    Biochem Biophys Res Commun; 2012 May; 421(4):640-5. PubMed ID: 22450326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of COX-2 activity and CRP levels in patients with non-melanoma skin cancer. -765G>C PTGS2 polymorphism and NMSC risk.
    Cocoş R; Schipor S; Nicolae I; Thomescu C; Raicu F
    Arch Dermatol Res; 2012 Jul; 304(5):335-42. PubMed ID: 22159575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematical analysis of cutaneous squamous cell carcinoma network of microRNAs, transcription factors, and target and host genes.
    Wang N; Xu ZW; Wang KH
    Asian Pac J Cancer Prev; 2014; 15(23):10355-61. PubMed ID: 25556475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and function of macrophage migration inhibitory factor in the pathogenesis of UV-induced cutaneous nonmelanoma skin cancer.
    Heise R; Vetter-Kauczok CS; Skazik C; Czaja K; Marquardt Y; Lue H; Merk HF; Bernhagen J; Baron JM
    Photochem Photobiol; 2012; 88(5):1157-64. PubMed ID: 22324658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between basal, squamous cell carcinomas, dysplastic nevi and myotonic muscular dystrophy indicates an important role of RNA-binding proteins in development of human skin cancer.
    Zemtsov A
    Arch Dermatol Res; 2010 Apr; 302(3):169-70. PubMed ID: 19902230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of eIF4E expression in skin squamous cell carcinoma.
    Salehi Z; Mashayekhi F; Shahosseini F
    Cell Biol Int; 2007 Nov; 31(11):1400-4. PubMed ID: 17689990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-221 and -222 pathway controls melanoma progression.
    Felicetti F; Errico MC; Segnalini P; Mattia G; Carè A
    Expert Rev Anticancer Ther; 2008 Nov; 8(11):1759-65. PubMed ID: 18983236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of miRNAs in cutaneous squamous cell carcinoma.
    Yu X; Li Z
    J Cell Mol Med; 2016 Jan; 20(1):3-9. PubMed ID: 26508273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of apoptosis in basal cell and squamous cell carcinoma formation.
    Erb P; Ji J; Wernli M; Kump E; Glaser A; Büchner SA
    Immunol Lett; 2005 Aug; 100(1):68-72. PubMed ID: 16054233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.